3//SEC Filing
Myrexis, Inc. 3
Accession 0000921895-20-000957
CIK 0000727510operating
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 6:30 PM ET
Size
4.9 KB
Accession
0000921895-20-000957
Insider Transaction Report
Form 3
Myrexis, Inc.
10% Owner
Holdings
- 250
Common Stock, $0.01 par value
Footnotes (1)
- [F1]The Reporting Person may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. The Reporting Person disclaims beneficial ownership of the securities of the Issuer owned by other members of the Section 13(d) group and this report shall not be deemed an admission that it is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Documents
Issuer
ENZON PHARMACEUTICALS, INC.
CIK 0000727510
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001459450
Filing Metadata
- Form type
- 3
- Filed
- Mar 30, 8:00 PM ET
- Accepted
- Mar 31, 6:30 PM ET
- Size
- 4.9 KB